20 May 2013
Keywords: xoma, posts, 22m, third, quarter, profit, drugmaker
Article | 19 November 2007
US drugmaker Xoma, a specialist in the development of therapeutic antibodies, swung to a third quarter profit of $21.8 million, or $0.16
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
17 May 2013
© 2013 thepharmaletter.com